METTL24
Probable methyltransferase-like protein 24
Also known as: C6orf186, dJ71D21.2, MET24_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JXM2
- Gene
- METTL24
- Ensembl
- ENSG00000053328
- Chromosome
- 6
- Canonical length
- 366 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to enable methyltransferase activity. Predicted to be involved in methylation. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
366 residues, UniProt reviewed canonical sequence.
>Q5JXM2|METTL24
1 MARERPPGRG CGVLRRCLLG AVLLFGLRLC AELRRAGPGS PTRSAPPGPA WRPPGPHLPP
61 APGQPRGASR RQVTYVRSGR RAPPGGGGSG TPEPGCCAPR GRPRRKGPRW HIDLQPWAGS
121 AQSLDEEAWR FLRYISTTQI ACNHMNTDSL ATDSSPTHKP WSVCLDDRFN LAHQIRNKQC
181 RLYSLGLGSD DTHFEVSMAN NGCEVHRFDP SVKSAHILES QHLWYHRLSI DWRDPHPAVA
241 AQKPHSNTRK LGSILNEFGH HKIDVLKADL ESAEWKVLEN LILEDVLEQI GQLIFEIHLH
301 WPGFEVSGSD SSVVRFWYSL LKELEQKDFR LFHSYKDLSK PQLFLKKDIF NASSCYTLSW
361 VNTRWKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against METTL24 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- smooth muscle: 11 nTPM
- colon: 9.5 nTPM
- blood vessel: 7 nTPM
- endometrium: 6.6 nTPM
- seminal vesicle: 6.2 nTPM
- ovary: 4.8 nTPM
Single-cell type
- choroid plexus epithelial cells: 189 nCPM
- pituitary stem cells: 183 nCPM
- gonadotrophs: 82 nCPM
- podocytes: 80 nCPM
- retinal horizontal cells: 70 nCPM
- lactotrophs: 67 nCPM
Immune cell
- MAIT T-cell: 2.4 nTPM
- memory CD8 T-cell: 0.5 nTPM
- T-reg: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
- NK-cell: 0.2 nTPM
- basophil: 0.1 nTPM
Brain region
- choroid plexus: 18 nTPM
- cerebellum: 13 nTPM
- cerebral cortex: 12 nTPM
- basal ganglia: 12 nTPM
- hippocampal formation: 11 nTPM
- hypothalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Methyltransferase domain
- Probable methyltransferase-like protein 24
- Methyltransferase domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads METTL24 as an antibody target. Whether an autoantibody or antibody against METTL24 could matter depends on whether native METTL24 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
METTL24 is annotated as secreted, so native METTL24 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label METTL24 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...